EndoChoice has a consensus revenue estimate of $74.51 million for fiscal year 2015.
EndoChoice is collaborating with De Lage Landen Financial Services to create a new financing option for customers interested in its Fuse Endoscopy system.
Clinical-stage biopharmaceutical company Spring Bank Pharmaceutical appointed Nezam Afdhal, MD, CMO.
Olympus introduced its CleverCut3V Distal Wireguided sphincterotome.
More articles on GI/endoscopy:
Exact Sciences to open biotech campus & more – 3 GI company key notes
CMS cuts to colonoscopy reimbursement finalized: 3 things to know
6 recent must-reads on CRC screening & treatments
